|
Volumn 40, Issue 3, 2011, Pages 327-331
|
[Efficacy of bismuth-based quadruple therapy as first-line treatment for Helicobacter pylori infection].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
ANTIULCER AGENT;
BISMUTH;
ADULT;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG COMBINATION;
ECONOMICS;
FEMALE;
FOLLOW UP;
HELICOBACTER INFECTION;
HUMAN;
MALE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
ANTI-BACTERIAL AGENTS;
ANTI-ULCER AGENTS;
BISMUTH;
COST-BENEFIT ANALYSIS;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HELICOBACTER INFECTIONS;
HUMANS;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
EID: 80053297876
PISSN: 10089292
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (0)
|